Abenavoli, L.; Scarlata, G.G.M.; Scarpellini, E.; Boccuto, L.; Spagnuolo, R.; Tilocca, B.; Roncada, P.; Luzza, F.
Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome. Medicina 2023, 59, 594.
https://doi.org/10.3390/medicina59030594
AMA Style
Abenavoli L, Scarlata GGM, Scarpellini E, Boccuto L, Spagnuolo R, Tilocca B, Roncada P, Luzza F.
Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome. Medicina. 2023; 59(3):594.
https://doi.org/10.3390/medicina59030594
Chicago/Turabian Style
Abenavoli, Ludovico, Giuseppe Guido Maria Scarlata, Emidio Scarpellini, Luigi Boccuto, Rocco Spagnuolo, Bruno Tilocca, Paola Roncada, and Francesco Luzza.
2023. "Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome" Medicina 59, no. 3: 594.
https://doi.org/10.3390/medicina59030594
APA Style
Abenavoli, L., Scarlata, G. G. M., Scarpellini, E., Boccuto, L., Spagnuolo, R., Tilocca, B., Roncada, P., & Luzza, F.
(2023). Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome. Medicina, 59(3), 594.
https://doi.org/10.3390/medicina59030594